Showing results (81-90 of 266) with videos related to

Sort By:
Pageof 27
Brain Research Bulletin|December 31, 2003
White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regionsDavid F Moore, Gheona Altarescu, W Craig Barker, et al.
The Journal of Pediatrics|September 13, 2003
Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3Ozlem Goker-Alpan, Raphael Schiffmann, Joseph K Park, et al.
Nephron|March 30, 2025
Further Clinical and Biochemical Phenotype of GLA p.A143T: A Fabry Disease Newborn Screening ExperienceAllison M Paltzer, Allegra M Quadri, Carly Rasmussen, et al.
Plos One|December 20, 2016
An Assessment of Publication Status of Pediatric Liver Transplantation StudiesThomas Breil, Daniel Wenning, Ulrike Teufel, et al.
Advances in Therapy|August 23, 2019
Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient SurveyOlivier Morand, Jack Johnson, Jerry Walter, et al.
BMC Cardiovascular Disorders|March 13, 2002
Arterial wall properties and Womersley flow in Fabry diseaseDavid F Moore, Gheona Altarescu, Randall Pursley, et al.
Biochemical and Biophysical Research Communications|October 15, 2005
Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domainKyun Oh Lee, Nga Luu, Christine R Kaneski, et al.
BMC Neurology|April 15, 2015
Neurogenic bladder and neuroendocrine abnormalities in Pol III-related leukodystrophyAna Potic, Vera Popovic, Jelena Ostojic, et al.
BMC Neurology|October 21, 2010
Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patientsLaetitia Horzinski, Liraz Kantor, Aurélia Huyghe, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 25, 2006
Fabry disease and vascular risk factors: future strategies for patient-based studies and the knockout murine modelDavid F Moore, Monique P Gelderman, Steven R Fuhrmann, et al.
Pageof 27